Symbiosis Pharmaceutical Services
Symbiosis Pharmaceutical Services is a leading provider of GMP sterile fill-finish manufacturing services, supporting clinical and small-scale commercial production of biologics, small molecules, and advanced therapeutics. Established in 2011, the company aims to accelerate drug development timelines with rapid access to manufacturing slots, operational flexibility, and tailored process solutions. Recognized with a King's Award for Enterprise, Symbiosis is committed to service excellence, innovation, and building long-term client relationships.
Industries
Nr. of Employees
medium (51-250)
Symbiosis Pharmaceutical Services
Products
Clinical-scale GMP manufacturing suites
Small-scale GMP manufacturing suites for clinical trial supply, including aseptic filling, analytical support and validation capabilities.
Commercial-scale aseptic filling capability (small volumes)
MHRA-licensed small-scale commercial aseptic filling for licensed biologic and small molecule products, supporting bulk volumes under 100 L and batch sizes up to ~3000 vials.
Bruce Building Aseptic Manufacturing Facility
A state-of-the-art, 20,000 sq ft facility dedicated to sterile manufacturing processes, featuring Annex 1 compliant cleanrooms, BSL-2 and cytotoxic capabilities, and high-speed automated filling.
Aseptic Filling Services
Fully licensed aseptic filling and manufacturing of liquid and lyophilised investigational and commercial products into vials, supporting various modalities from conventional small molecules to cytotoxics, biologics, and viral vectors.
Aseptic Commercial API Manufacturing
Our aseptic commercial biologics manufacturing services are ideally suited for companies involved in niche markets and orphan indications that require relatively low volume sterile fill-finish to reflect patient demands.
Clinical and commercial aseptic manufacturing
MHRA-licensed and FDA-inspected GMP facilities providing flexible aseptic fill-finish manufacturing for viral vectors, plasmids, monoclonal antibodies, proteins, peptides, RNA, cytotoxic, cytostatic, and high potent APIs including ADCs.
Clinical-scale GMP manufacturing suites
Small-scale GMP manufacturing suites for clinical trial supply, including aseptic filling, analytical support and validation capabilities.
Commercial-scale aseptic filling capability (small volumes)
MHRA-licensed small-scale commercial aseptic filling for licensed biologic and small molecule products, supporting bulk volumes under 100 L and batch sizes up to ~3000 vials.
Bruce Building Aseptic Manufacturing Facility
A state-of-the-art, 20,000 sq ft facility dedicated to sterile manufacturing processes, featuring Annex 1 compliant cleanrooms, BSL-2 and cytotoxic capabilities, and high-speed automated filling.
Aseptic Filling Services
Fully licensed aseptic filling and manufacturing of liquid and lyophilised investigational and commercial products into vials, supporting various modalities from conventional small molecules to cytotoxics, biologics, and viral vectors.
Aseptic Commercial API Manufacturing
Our aseptic commercial biologics manufacturing services are ideally suited for companies involved in niche markets and orphan indications that require relatively low volume sterile fill-finish to reflect patient demands.
Clinical and commercial aseptic manufacturing
MHRA-licensed and FDA-inspected GMP facilities providing flexible aseptic fill-finish manufacturing for viral vectors, plasmids, monoclonal antibodies, proteins, peptides, RNA, cytotoxic, cytostatic, and high potent APIs including ADCs.
Services
GMP aseptic filling of liquid and lyophilised parenteral products for clinical and small-scale commercial supply.
Bulk freeze-drying services including loading and execution of lyophilisation campaigns for GMP material.
Analytical testing to support GMP release and quality control of drug products.
Preparation, labelling and packaging of investigational medicinal products for clinical trials.
QP services for batch certification and regulatory support for product release and licensing.
Process development, scale-up support and transfer of processes to GMP manufacturing including validation and PPQ support.
GMP aseptic filling of liquid and lyophilised parenteral products for clinical and small-scale commercial supply.
Bulk freeze-drying services including loading and execution of lyophilisation campaigns for GMP material.
Analytical testing to support GMP release and quality control of drug products.
Preparation, labelling and packaging of investigational medicinal products for clinical trials.
QP services for batch certification and regulatory support for product release and licensing.
Process development, scale-up support and transfer of processes to GMP manufacturing including validation and PPQ support.
Expertise Areas
- Aseptic fill-finish for clinical and small commercial supply
- Lyophilisation and freeze-drying processes
- Advanced therapy (viral vector) and ATMP manufacturing
- RNA/oligonucleotide formulation and fill-finish
Key Technologies
- Aseptic filling systems
- Bulk lyophilisation (freeze-drying)
- BSL-2 containment suites
- Viral vector manufacture and handling
News & Updates
Symbiosis has been awarded a 2025 King’s Award for Enterprise in the International Trade category.
Recognition for excellence in international trade.
Symbiosis has been awarded a 2025 King’s Award for Enterprise in the International Trade category.
Recognition for excellence in international trade.